U.S. market Closed. Opens in 11 hours 52 minutes

GRI | GRI Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue21.77MN/AN/A100.00KN/A
Cost of Revenue57.00K206.00K73.00KN/A735.00
Gross Profit21.71M-206.00K-73.00K100.00K-735.00
Operating Expenses11.33M2.24M1.06M4.81M3.15M
Selling, General & Admin8.10M2.00M813.00K1.11M1.27M
Research & Development3.23M242.00K249.00K3.71M1.88M
Other Operating Expenses102.00KN/AN/AN/AN/A
Operating Income-11.39M-2.24M-1.06M-4.79M-3.15M
Other Expenses / Income-1.65M-978.00K-497.00K-34.00K-310.07K
Before Tax Income-13.04M-3.22M-1.56M-4.82M-3.46M
Income Tax Expenses-110.89K325.00K-50.00K-131.30K5.00
Net Income-13.04M-3.54M-1.51M-4.82M-3.46M
Interest Expenses2.08M653.00K547.00K34.00K197.03K
Basic Shares Outstanding461.57K420.00K324.42K324.33K324.33K
Diluted Shares Outstanding461.57K420.00K324.42K324.33K324.33K
EBITDA-11.33M-2.19M-1.01M-4.71M-3.15M
EBITDA Margin-52.05%0.00%0.00%-4,713.00%0.00%
EBIT-11.07M-2.56M-1.01M-4.92M-3.27M
EBIT Margin-50.84%0.00%0.00%-4,919.30%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙